...
首页> 外文期刊>Medicine. >Identification of a PRKAR1A mutation (c.491_492delTG) in familial cardiac myxoma: A case report
【24h】

Identification of a PRKAR1A mutation (c.491_492delTG) in familial cardiac myxoma: A case report

机译:家族性心脏粘液瘤中PRKAR1A突变(c.491_492delTG)的鉴定:一例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Rationale: Cardiac myxoma is the most common cardiac neoplasm. Currently, there are not many reports on familial cardiac myxoma . Herein, we reported 2 first-degree relatives with left atrial myxoma. Patient concerns: A 20-year-old female was admitted in our hospital for lapsing into a coma for 24 hours, and was diagnosed with recurrent left atrial cardiac myxoma . The patient's father also had a history of cardiac myxoma . Diagnosis : The patient was diagnosed with left atrial myxoma using transthoracic echocardiography (TTE). Whole exome sequencing (WES) identified a p.Val164Aspfs (c.491-492delTG) mutation in the cAMP-dependent protein kinase A (PKA) regulatory (R) subunit 1 ( PRKAR1A ) gene for both the proband and her father, but not in her uncle and brother, who had not shown manifestation of cardiac myxoma by the time of this report. Interventions: The myxoma resection was performed following the standard procedure of open chest surgery. Outcomes: The tumor was successfully removed along with the tuberculum. The patient recovered well and was discharged home. No recurrence occurred during 1-year follow-up. Lessons: Our findings suggest that PRKAR1A mutation (c.491_492delTG) may be associated with cardiac myxoma , and genetic counseling and specific locus mutation tests may contribute to assessing the risk of cardiac myxoma .
机译:理由:心脏粘液瘤是最常见的心脏肿瘤。目前,关于家族性心脏粘液瘤的报道还很少。在此,我们报道了2名患有左房粘液瘤的一级亲属。患者担忧:一名20岁女性因昏迷昏迷24小时而入院,并被诊断出左心房粘液瘤复发。病人的父亲也有心脏粘液瘤病史。诊断:经胸超声心动图(TTE)诊断为左房粘液瘤。整个外显子组测序(WES)在先证人及其父亲的cAMP依赖性蛋白激酶A(PKA)调节(R)亚基1(PRKAR1A)基因中鉴定出p.Val164Aspfs(c.491-492delTG)突变,但未发现她的叔叔和弟弟在本报告撰写之时尚未表现出心脏粘液瘤的表现。干预:粘液瘤切除是按照开胸手术的标准程序进行的。结果:肿瘤与结核一起成功切除。病人康复良好,已出院。在一年的随访中未发生复发。经验教训:我们的发现表明PRKAR1A突变(c.491_492delTG)可能与心脏粘液瘤有关,而遗传咨询和特定基因座突变试验可能有助于评估心脏粘液瘤的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号